A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer

✍ Scribed by Michael Friedlander; Kenneth C. Hancock; Danny Rischin; Mark J. Messing; Claude A. Stringer; Gemma M. Matthys; Bo Ma; Jeffrey P. Hodge; Joanne J. Lager

• Book ID: 113962519
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 332 KB
• Volume: 119
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2010.05.033